BPC-157 10mg

What is BPC-157?

BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a protective sequence identified in human gastric juice. The name itself — "body protection" compound — comes from that origin. It is a stable fragment, which is one of the reasons it has attracted so much attention as a reference peptide in tissue-repair research studies.

BPC-157 mechanism of action

Published preclinical work has explored several proposed mechanisms:

• Growth factor upregulation. Studies report increased expression of vascular endothelial growth factor (VEGF) and other growth factor pathways associated with angiogenesis.
• Nitric oxide (NO) system modulation. BPC-157 has been described as interacting with the NO pathway, which is central to blood-vessel formation and repair signaling.
• Cell migration and fibroblast activity. In-vitro assays have observed accelerated cell migration and fibroblast proliferation, both foundational steps in tissue remodeling.
• Gastrointestinal protection. Because the parent sequence was isolated from gastric juice, a substantial portion of the literature focuses on GI-tract models.

Research studies at a glance

Most BPC-157 research studies fall into one of these buckets:

• Tendon and ligament repair models — often referenced in the context of knee pain and joint injury research.
• Muscle and soft-tissue models — evaluating recovery markers versus a control group.
• Gastrointestinal ulceration models — one of the earliest and best-documented lines of work.
• Neuroprotection and CNS models — a smaller but growing body of preclinical work.
• Cancer cells assays — some in-vitro work has looked at how BPC-157 interacts with cancer cells, but findings are preliminary and not conclusive.

Most published data comes from animal or in-vitro settings. Human clinical trials remain limited, and long term data in humans is not established.

Regulatory and compliance context

BPC-157 is not an FDA-approved drug. It has been placed on the World Anti-Doping Agency (WADA) Prohibited List, so any athletic use would be considered doping. It is legal to purchase in the United States as a reference compound for in-vitro laboratory research only. It is not intended for human or veterinary use.

Safety and side effects (research context)

Published animal studies generally report a favorable short-term tolerability profile, but robust human safety data — including side effects, drug interactions, and long term exposure outcomes — has not been established. Researchers should design protocols with a proper control group and follow their institution's safety guidelines.

Storage, handling, and reconstitution

BPC-157 ships as lyophilized powder sealed under nitrogen. Store unopened vials refrigerated at 2–8°C for long-term stability. Reconstitute with bacteriostatic water by injecting it down the side of the vial and swirling gently — never shake. Keep reconstituted material refrigerated and use within the compound's documented stability window.